KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Insulet (PODD) Other Operating Expenses (2016 - 2019)

Historic Other Operating Expenses for Insulet (PODD) over the last 11 years, with Q4 2019 value amounting to -$135.0 million.

  • Insulet's Other Operating Expenses fell 2783.49% to -$135.0 million in Q4 2019 from the same period last year, while for Sep 2020 it was -$135.0 million, marking a year-over-year decrease of 55926.09%. This contributed to the annual value of $124.2 million for FY2017, which is 3145.22% up from last year.
  • Insulet's Other Operating Expenses amounted to -$135.0 million in Q4 2019, which was down 2783.49% from $47.2 million recorded in Q3 2019.
  • Insulet's 5-year Other Operating Expenses high stood at $47.2 million for Q3 2019, and its period low was -$135.0 million during Q4 2019.
  • Over the past 5 years, Insulet's median Other Operating Expenses value was $26.7 million (recorded in 2016), while the average stood at $14.9 million.
  • In the last 5 years, Insulet's Other Operating Expenses skyrocketed by 22610.88% in 2015 and then tumbled by 37847.65% in 2018.
  • Over the past 5 years, Insulet's Other Operating Expenses (Quarter) stood at $23.4 million in 2015, then increased by 8.48% to $25.4 million in 2016, then skyrocketed by 49.47% to $37.9 million in 2017, then crashed by 378.48% to -$105.6 million in 2018, then dropped by 27.83% to -$135.0 million in 2019.
  • Its Other Operating Expenses was -$135.0 million in Q4 2019, compared to $47.2 million in Q3 2019 and $46.7 million in Q2 2019.